NCT05774704View on ClinicalTrials.gov

Curcumin and Retinal Study

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
BioavailabilityGut MicrobiomeSafety
Interventions
DRUG

Low curcumin group

One curcumin capsule (250 mg curcumin) after each meal, 3 times a day for 2 weeks.

DRUG

High curcumin group

One curcumin capsule (500 mg curcumin) after each meal, 3 times a day for 2 weeks.

Trial Locations (1)

79430

RECRUITING

Texas Tech University Health Sciences Center, Lubbock

All Listed Sponsors
lead

Texas Tech University Health Sciences Center

OTHER